{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:50:15Z","timestamp":1772527815889,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Clinical Research Project of Shanghai Municipal Health Commission","award":["202040328"],"award-info":[{"award-number":["202040328"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>PIK3CA<\/jats:italic>-related overgrowth spectrum (PROS) is a series of congenital, sporadic disorders that are associated with segmental overgrowth phenotypes and postzygotic, somatic gene mutations in the PIK3CA-ATK-mTOR pathway. The variability and overlapping phenotypes between PROS and other complex vascular malformations make the differential diagnosis confusing and challenging. PROS should be considered for the differential diagnosis with other complex vascular malformations and syndromes with a tissue overgrowth phenotype, such as Parkes-Weber syndrome (PWS).<\/jats:p><jats:p>Herein, we diagnosed one unique clinically challenging case manifested as capillary malformation (CM), limb overgrowth, as well as increased skin temperature and peripheral venous dilatation of lower limb that indicated a potential fast-flow lesion. The patient was initially diagnosed with PWS. Contrary to the previous diagnosis, based on further MR imaging and digital subtraction angiography (DSA), which ruled out the existence of AVMs and AVFs, and molecular analysis with targeted next-generation sequencing (NGS) revealing a somatic PIK3CA mutation, we ultimately diagnosed that the patient had a unique form of PROS simulating PWS phenotypes. We suggest that it is important to propose the differential diagnosis of PWS and PROS, two diseases that share a common overgrowth phenotype. We recommended radiological diagnosis such as MRI, CT and DSA as well as further molecular diagnosis to provide more information for the assessment of vascular lesions and to further guide clinical treatment strategies.<\/jats:p>","DOI":"10.1186\/s41065-021-00217-6","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T01:02:38Z","timestamp":1641258158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complex vascular anomalies and tissue overgrowth of limbs associated with increased skin temperature and peripheral venous dilatation: parks weber syndrome or PROS?"],"prefix":"10.1186","volume":"159","author":[{"given":"Li Xin","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianzhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhe","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xindong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-0170","authenticated-orcid":false,"given":"Ren","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"2","key":"217_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167(2):287\u201395.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"217_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","volume":"164","author":"KM Keppler-Noreuil","year":"2014","unstructured":"Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164(7):1713\u201333.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"217_CR3","first-page":"989","volume":"19","author":"P Kuentz","year":"2017","unstructured":"Kuentz P, St-Onge J, Duffourd Y, et al. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Gen Med. 2017;19(9):989\u201397.","journal-title":"Gen Med"},{"issue":"1","key":"217_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01929-8","volume":"16","author":"G Canaud","year":"2021","unstructured":"Canaud G, Hammill AM, Adams D, Vikkula M, Keppler-Noreuil KM. A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis. 2021;16(1):1\u201310.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"217_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1148\/rg.2019180136","volume":"39","author":"F Bertino","year":"2019","unstructured":"Bertino F, Braithwaite KA, Hawkins CM, et al. Congenital limb overgrowth syndromes associated with vascular anomalies. Radiographics. 2019;39(2):491\u2013515.","journal-title":"Radiographics"},{"issue":"1","key":"217_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/exd.12826","volume":"25","author":"H Vahidnezhad","year":"2016","unstructured":"Vahidnezhad H, Youssefian L, Uitto J. Klippel\u2013Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol. 2016;25(1):17\u20139.","journal-title":"Exp Dermatol"},{"issue":"1","key":"217_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cge.12832","volume":"91","author":"A Martinez-Lopez","year":"2017","unstructured":"Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, et al. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet. 2017;91(1):14\u201321.","journal-title":"Clin Genet"},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.nephro.2017.02.004","volume":"13","author":"Q Venot","year":"2017","unstructured":"Venot Q, Canaud G. PIK3CA-related overgrowth syndrome (PROS). Nephrol Ther. 2017;13:S155\u20136.","journal-title":"Nephrol Ther"},{"issue":"8","key":"217_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ng.2332","volume":"44","author":"MJ Lindhurst","year":"2012","unstructured":"Lindhurst MJ, Parker VE, Payne F, et al. Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet. 2012;44(8):928\u201333.","journal-title":"Nat Genet"},{"issue":"1","key":"217_CR10","doi-asserted-by":"publisher","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","volume":"133","author":"RA Maclellan","year":"2014","unstructured":"Maclellan RA, Luks VL, Vivero MP, et al. PIK3CA activating mutations in facial infiltrating lipomatosis. Plastic Reconstr Surg. 2014;133(1):12e\u20139e.","journal-title":"Plastic Reconstr Surg"},{"issue":"1","key":"217_CR11","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.jpedsurg.2009.10.059","volume":"45","author":"\u00d6 Boybeyi","year":"2010","unstructured":"Boybeyi \u00d6, Alanay Y, Kay\u0131k\u00e7\u0131o\u011flu A, Karnak \u0130. Hemihyperplasia-multiple lipomatosis syndrome: an underdiagnosed entity in children with asymmetric overgrowth. J Pediatr Surg. 2010;45(1):e19\u201323.","journal-title":"J Pediatr Surg"},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ajmg.c.31361","volume":"163C","author":"GM Mirzaa","year":"2013","unstructured":"Mirzaa GM, RIVI\u00c8RE JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Gen C Semin Med Genet. 2013;163C:122\u201330.","journal-title":"Am J Med Gen C Semin Med Genet"},{"issue":"10","key":"217_CR13","first-page":"1111","volume":"175","author":"H Vahidnezhad","year":"2016","unstructured":"Vahidnezhad H, Youssefian L, Baghdadi T, et al. Phenotypic heterogeneity in PIK3CA-related overgrowth spectrum (PROS). British J Dermatol. 2016;175(10):1111.","journal-title":"British J Dermatol"},{"issue":"6","key":"217_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0268355516664212","volume":"32","author":"I Banzic","year":"2017","unstructured":"Banzic I, Brankovic M, Maksimovi\u0107 \u017d, Davidovi\u0107 L, Markovi\u0107 M, Ran\u010di\u0107 Z. Parkes weber syndrome\u2014diagnostic and management paradigms: a systematic review. Phlebology. 2017;32(6):371\u201383.","journal-title":"Phlebology"},{"issue":"2","key":"217_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2021192803","volume":"299","author":"F Ufuk","year":"2021","unstructured":"Ufuk F. Case 289: PIK3CA-related overgrowth Spectrum (PROS): CLOVES syndrome and coexisting Fibroadipose vascular anomaly. Radiology. 2021;299(2):486\u201390.","journal-title":"Radiology"},{"issue":"11","key":"217_CR16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00330-004-2274-8","volume":"14","author":"S Ziyeh","year":"2004","unstructured":"Ziyeh S, Spreer J, R\u00f6ssler J, et al. Parkes weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography. Eur Radiol. 2004;14(11):2025\u20139.","journal-title":"Eur Radiol"},{"issue":"7","key":"217_CR17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/humu.20746","volume":"29","author":"N Revencu","year":"2008","unstructured":"Revencu N, Boon LM, Mulliken JB, et al. Parkes weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29(7):959\u201365.","journal-title":"Hum Mutat"},{"key":"217_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-46709-1_8","volume-title":"ISSVA Classification of Vascular Anomalies","author":"F Blei","year":"2017","unstructured":"Blei F. ISSVA Classification of Vascular Anomalies; 2017."},{"issue":"19","key":"217_CR19","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/ajmg.a.31333","volume":"140A","author":"MM Cohen Jr","year":"2010","unstructured":"Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A. 2010;140A(19):2013\u201338.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"217_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.otc.2017.09.006","volume":"51","author":"A Queisser","year":"2018","unstructured":"Queisser A, Boon LM, Vikkula M. Etiology and genetics of congenital vascular lesions. Otolaryngol Clin N Am. 2018;51(1):41\u201353.","journal-title":"Otolaryngol Clin N Am"},{"issue":"7","key":"217_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1104017","volume":"365","author":"MJ Lindhurst","year":"2011","unstructured":"Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med. 2011;365(7):611\u20139.","journal-title":"N Engl J Med"},{"issue":"7711","key":"217_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018;558(7711):540.","journal-title":"Nature"},{"issue":"5","key":"217_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","volume":"21","author":"VE Parker","year":"2019","unstructured":"Parker VE, Keppler-Noreuil KM, Faivre L, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21(5):1189\u201398.","journal-title":"Genet Med"},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"732836","DOI":"10.3389\/fped.2021.732836","volume":"9","author":"A Pagliazzi","year":"2021","unstructured":"Pagliazzi A, Oranges T, Traficante G, et al. PIK3CA-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib. Front Pediatr. 2021;9:732836.","journal-title":"Front Pediatr"},{"issue":"2","key":"217_CR25","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137(2):e20153257.","journal-title":"Pediatrics"},{"issue":"6","key":"217_CR26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018\u201324.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-021-00217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-021-00217-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-021-00217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T13:21:52Z","timestamp":1641302512000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-021-00217-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1186\/s41065-021-00217-6","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient give written informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient give written informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}